Pfizer Exec: Wyeth Added Value to Drug Pipeline

Martin Mackay, president of Pfizer Inc.’s PharmaTherapeutics research division, told a healthcare conference Tuesday in San Francisco that the company received “great additions to the pipeline” when it acquired Wyeth Pharmaceuticals late last year.
The Day